Michael Dworzak

15.2k total citations
189 papers, 5.8k citations indexed

About

Michael Dworzak is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Michael Dworzak has authored 189 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Hematology, 105 papers in Public Health, Environmental and Occupational Health and 48 papers in Molecular Biology. Recurrent topics in Michael Dworzak's work include Acute Myeloid Leukemia Research (105 papers), Acute Lymphoblastic Leukemia research (103 papers) and Chronic Myeloid Leukemia Treatments (33 papers). Michael Dworzak is often cited by papers focused on Acute Myeloid Leukemia Research (105 papers), Acute Lymphoblastic Leukemia research (103 papers) and Chronic Myeloid Leukemia Treatments (33 papers). Michael Dworzak collaborates with scholars based in Austria, Germany and Czechia. Michael Dworzak's co-authors include Dirk Reinhardt, Ursula Creutzig, Helmut Gadner, Martin Zimmermann, Jan Starý, Georg Mann, Thomas Lehrnbecher, Ulrike Pötschger, Andishe Attarbaschi and Dieter Printz and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Dworzak

186 papers receiving 5.7k citations

Peers

Countries citing papers authored by Michael Dworzak

Since Specialization

Citations

This map shows the geographic impact of Michael Dworzak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Dworzak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Dworzak more than expected).

Fields of papers citing papers by Michael Dworzak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Dworzak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Dworzak. The network helps show where Michael Dworzak may publish in the future.

Co-authorship network of co-authors of Michael Dworzak

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Dworzak. A scholar is included among the top collaborators of Michael Dworzak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Dworzak. Michael Dworzak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic Value of Molecular Genetic Measurable Residual Disease ( MRD ) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10 2025 ·European Journal Of Haematology ·(unknown), (unknown), Mareike Rasche, Martina Pigazzi, Claudia Tregnago, (unknown), Christiane Walter, Michael Dworzak, Nora Mühlegger, Nils von Neuhoff, Franco Locatelli, Dirk Reinhardt, Markus Schneider	1
2	Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12 2025 ·Nature Communications ·(unknown), Thomas Eder, (unknown), (unknown), Pablo Fernández‐Pernas, Johannes Schmoellerl, (unknown), Gabriele Manhart, (unknown), Margarita Maurer‐Granofszky, (unknown), Karin Nebral, Giulio Superti‐Furga, Roland Meisel, Beat Bornhäuser, Peter Valent, Michael Dworzak, Johannes Zuber, Kaan Boztuǧ, Florian Grebien	1
3	Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms 2024 ·Nature Communications ·(unknown), Jurrian K. de Kanter, (unknown), Mark Verheul, (unknown), Markus J. van Roosmalen, Henrik Hasle, (unknown), Dirk Reinhardt, Michael Dworzak, Nora Mühlegger, Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan, Bianca F. Goemans, Ruben van Boxtel	8
4	Importance of genetic clarification in cytopenia syndromes (childhood myelodysplastic syndrome forms) 2024 ·memo - Magazine of European Medical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Ingrid Simonitsch‐Klupp, Heidrun Boztug, Gernot Engstler, Leo Kager, Kaan Boztuǧ, Michael Dworzak	0
5	FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report 2023 ·Cytometry Part A ·(unknown), Margarita Maurer‐Granofszky, (unknown), (unknown), Michael J. Reiter, Angela Schumich, (unknown), (unknown), Michaela Nováková, (unknown), Giuseppe Gaipa, Ondřej Hrušák, Barbara Buldini, Michael Dworzak	6
6	Treatment of Molecular Relapses in Pediatric AML Saves Toxicities Prior to Hematopoietic Stem Cell Transplantation (HSCT) - Results of AMoRe2017 Trial 2023 ·Blood ·(unknown), Dirk Reinhardt, André Baruchel, Henrik Hasle, Franco Locatelli, C. Michel Zwaan, Michael C. Frühwald, (unknown), Michael Dworzak, Heidrun Boztug, (unknown), Thomas Lehrnbecher, Bianca F. Goemans, Brigitte Strahm, Markus Schneider, (unknown), (unknown)	0
7	Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course 2022 ·Annals of Hematology ·(unknown), Jérémie Rouger, David Brossier, Meinolf Suttorp, Adalet Meral Güneş, Petr Sedláček, Birgitta Versluys, Chi Kong Li, Krzysztof Kałwak, Birgitte Lausen, (unknown), Michael Dworzak, (unknown), Barbara De Moerloose, (unknown), Anaïs R. Briant, Jean‐Jacques Parienti, Frédéric Millot	4
8	Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group 2021 ·Cancers ·Mareike Rasche, (unknown), Martin Zimmermann, Jean‐Pierre Bourquin, Heidrun Boztug, (unknown), E. Anders Kolb, Thomas Lehrnbecher, Nils von Neuhoff, Naghmeh Niktoreh, Nora Mühlegger, Lucie Šrámková, Jan Starý, Christiane Walter, Ursula Creutzig, Michael Dworzak, Dirk Reinhardt	15
9	Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry 2020 ·Pediatric Blood & Cancer ·Adalet Meral Güneş, Frédéric Millot, Krzysztof Kałwak, Birgitte Lausen, Petr Sedláček, Birgitta Versluys, Michael Dworzak, Barbara De Moerloose, Meinolf Suttorp	10
10	Advanced Phases at Diagnosis of Childhood Chronic Myeloid Leukemia : The Experience of the International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study) 2017 ·Blood ·Frédéric Millot, Joëlle Guilhot, Meinolf Suttorp, (unknown), (unknown), Petr Sedláček, Eveline S. de Bont, Chi Kong Li, Krzysztof Kałwak, Birgitte Lausen, (unknown), Michael Dworzak, (unknown), Barbara De Moerloose, Roula Farah, Andrea Biondi, André Baruchel	6
11	Long-term results of the 'Prospective study of the diagnosis and treatment of myelodysplastic syndromes in childhood (EWOG-MDS98)' 2015 ·Haematologica ·(unknown), Ayami Yoshimi, Irith Baumann, Marek Ussowicz, Barbara De Moerloose, Brigitte Schlegelberger, Michael Dworzak, Markus Schmugge, Marco Zecca, Alexandra Fischer, Peter Nöllke, (unknown), Jan Starý, Henrik Hasle, Francesco Locatelli, C. Niemeyer	3
12	Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004 2013 ·Blood ·Ursula Creutzig, Martin Zimmermann, Jean‐Pierre Bourquin, Michael Dworzak, Gudrun Fleischhack, Norbert Graf, Thomas Klingebiel, Bernhard Kremens, Thomas Lehrnbecher, Christine von Neuhoff, J. Ritter, Annette Sander, André Schrauder, Arend von Stackelberg, Jan Starý, Dirk Reinhardt	123
13	Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium 2013 ·Journal of Clinical Oncology ·C. Michel Zwaan, Carmelo Rizzari, Françoise Méchinaud, (unknown), Thomas Lehrnbecher, Vincent H. J. van der Velden, Berna Beverloo, Monique L. den Boer, Rob Pieters, Dirk Reinhardt, Michael Dworzak, Julie Rosenberg, George Manos, Shruti Agrawal, Lewis C. Strauss, André Baruchel, Pamela Kearns	66
14	Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group 2013 ·Journal of Clinical Oncology ·Gertjan J.L. Kaspers, Martin Zimmermann, Dirk Reinhardt, Brenda Gibson, R. Y. J. Tamminga, Olga Aleinikova, (unknown), Michael Dworzak, Sy Ha, Henrik Hasle, Liisa Hovi, Alexei Maschan, Yves Bertrand, Guy Leverger, Bassem I. Razzouk, Carmelo Rizzari, Petr Smíšek, Owen Smith, Batia Stark, Ursula Creutzig	152
15	CNS irradiation in pediatric acute myleoid leukemia: Equal results by 12 or 18 Gy in studies AML‐BFM98 and 2004 2011 ·Pediatric Blood & Cancer ·Ursula Creutzig, Martin Zimmermann, Jean‐Pierre Bourquin, Michael Dworzak, Gudrun Fleischhack, Christine von Neuhoff, Annette Sander, André Schrauder, Arend von Stackelberg, J. Ritter, Jan Starý, Dirk Reinhardt	19
16	Immunosuppressive therapy with anti-thymocyte globin and cyclosporine A in patients with refractory cytopenia in childhood 2011 ·Bone Marrow Transplantation ·(unknown), (unknown), Ingo Baumann, Monika Führer, Barbara De Moerloose, Michael Dworzak, Jan Starý, Markus Schmugge, Marco Zecca, Peter Nöllke, Alain Fischer, Franco Locatelli, Brigitte Strahm, C. Niemeyer	1
17	Granulocyte Colony-Stimulating Factor (G-CSF) Treatment of Childhood Acute Myeloid Leukemias That Overexpress the Differentiation-Defective G-CSF Receptor Isoform IV Is Associated With a Higher Incidence of Relapse 2010 ·Journal of Clinical Oncology ·(unknown), (unknown), Martin Zimmermann, (unknown), Manuela Germeshausen, Nils von Neuhoff, C. Michel Zwaan, Katarina Reinhardt, Iris H.I.M. Hollink, Jan‐Henning Klusmann, Thomas Lehrnbecher, (unknown), Jan Starý, Michael Dworzak, Karl Welte, Ursula Creutzig, Dirk Reinhardt	47
18	Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow 2009 ·Journal of Clinical Oncology ·Giuseppe Basso, Marinella Veltroni, Maria Grazia Valsecchi, Michael Dworzak, Richard Ratei, Daniela Silvestri, (unknown), Barbara Buldini, Oscar Maglia, Giuseppe Masera, Valentino Conter, Maurizio Aricò, Andrea Biondi, Giuseppe Gaipa	181
19	Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis 2004 ·Leukemia ·Andishe Attarbaschi, Georg Mann, Margit König, Michael Dworzak, M. Trebo, Nora Mühlegger, Helmut Gadner, Oskar A. Haas, (unknown)	58
20	Reduced Interferon- γ Expression in Peripheral Blood Mononuclear Cells of Infants with Severe Respiratory Syncytial Virus Disease 1999 ·American Journal of Respiratory and Critical Care Medicine ·Judith H. Aberle, Stephan W. Aberle, Michael Dworzak, Christian W. Mandl, Winfried Rebhandl, (unknown), Michael Kundi, Therese Popow‐Kraupp	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact